Table 3 Antimicrobial susceptibility patterns of bacterial isolates from blood cultures of patients attending at AMGH, southern Ethiopia.
Bacterial species | Total n (%) | S R n (%) | Antimicrobial agents tested | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P | FOX | TC | CN | ERY | CIP | DOX | CHL | VAN | AMP | PIP | CRO | CFP | AUG | MEP | |||
S. aureus | 7 (31.8) | S R | 2 (29) 5 (71) | 3 (43) 4 (57) | 4 (57) 3 (43) | 4 (57) 3 (43) | 5 (71) 2 (29) | 4 (57) 3 (43) | 3 (43) 4 (57) | 4 (57) 3 (43) | NT | NT | NT | NT | NT | NT | NT |
Enterococci spp. | 4 (18.2) | S R | 1 (25) 3 (75) | NT | NT | NT | 2 (50) 2 (50) | NT | 1 (25) 3 (75) | 2 (50) 2 (50) | 3 (75) 1 (25) | NT | NT | NT | NT | NT | NT |
CoNS | 2 (9.1) | S R | ‒ 2 (100) | 1 (50) 1 (50) | 1 (50) 1 (50) | 2 (100) ‒ | 2 (100) ‒ | 1 (50) 1 (50) | 1 (50) 1 (50) | 1 (50) 1 (50) | NT | NT | NT | NT | NT | NT | NT |
Klebsiella spp. | 4 (18.2) | S R | NT | NT | 2 (50) 2 (50) | 3 (75) 1 (25) | NT | 3 (75) 1 (25) | NT | 1 (25) 3 (75) | NT | 1 (25) 3 (75) | NT | 1 (25) 3 (75) | 2 (50) 2 (50) | 1 (25) 3 (75) | 4 (100) ‒ |
E. coli | 2 (9.1) | S R | NT | NT | 1 (50) 1 (50) | 1 (50) 1 (50) | NT | 2 (100) ‒ | NT | 1 (50) 1 (50) | NT | ‒ 2 (100) | NT | ‒ 2 (100) | 2 (100) ‒ | 1 (50) 1 (50) | 2 (100) ‒ |
P. aeruginosa | 2 (9.1) | S R | NT | NT | NT | 1 (50) 1 (50) | NT | 1 (50) 1 (50) | NT | NT | NT | NT | ‒ 2 (100) | NT | 1 (50) 1 (50) | NT | 2 (100) ‒ |
Enterobacter spp. | 1 (4.5) | S R | NT | NT | 1 (100) ‒ | 1 (100) ‒ | NT | 1 (100) | NT | 1 (100) ‒ | NT | ‒ 1 (100) | NT | 1 (100) ‒ | 1 (100) ‒ | 1 (100) ‒ | 1 (100) ‒ |
Total isolates | 22 (100) | S R | 3 (23.1) 10 (76.9) | 4 (44.5) 5 (55.5) | 9 (56.3) 7 (43.7) | 12 (66.6) 6 (33.83) | 9 (69.2) 4 (30.7) | 12 (66.7) 6 (33.3) | 5 (38.5) 8 (61.4) | 10 (50) 10 (50) | 3 (75) 1 (25) | 1 (14.3) 6 (85.7) | ‒ 2 (100) | 2 (28.6) 5 (71.4) | 6 (66) (33) | 3 (42.9) 4 (57.1) | 9 (100) ‒ |
